Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Nunez; Gabriel
Address:
Ann Arbor, MI
No. of patents:
14
Patents:












Patent Number Title Of Patent Date Issued
7375086 Modulators of Nod2 signaling May 20, 2008
The present invention relates to intracellular signaling molecules, in particular the Nod2 protein and nucleic acids encoding the Nod2 protein. The present invention provides methods of identifying modulators of Nod2 signaling. In particular, the present invention additionally provides
7244557 Method of screening modulators of Nod1 signaling July 17, 2007
The present invention relates to intracellular signaling molecules, in particular the Nod1 protein. The present invention provides methods of identifying modulators of Nod1 signaling. The present invention further provides methods of altering Nod1 signaling.
7176019 RICK3 nucleic acids and proteins February 13, 2007
The present invention related to methods and compositions for modulating cellular signaling. In particular, the present invention relates to PKK and RICK3 proteins. The present invention further relates the to use of PKK and RICK3 proteins in modulating NF-.kappa.B signaling. The present
7060493 Nod2 nucleic acids and proteins June 13, 2006
The present invention relates to intracellular signalling molecules, in particular the Nod2 protein and nucleic acids encoding the Nod2 protein. The present invention provides isolated nucleotide sequence encoding Nod2, isolated Nod2 peptides, antibodies that specifically bind Nod2,
7060442 Modulators on Nod2 signaling June 13, 2006
The present invention relates to intracellular signaling molecules, in particular the Nod2 protein and nucleic acids encoding the Nod2 protein. The present invention provides methods of identifying modulators of Nod2 signaling. In particular, the present invention additionally provides
7041491 NOD nucleic acids and polypeptides May 9, 2006
The present invention relates to the NOD proteins and nucleic acids encoding the NOD proteins. The present invention further provides assays for the detection of NOD polymorphisms and mutations associated with disease states, as well as methods of screening for ligands and modulators
6911532 Vertebrate apoptosis gene: compositions and methods June 28, 2005
The invention relates generally to compositions of and methods for obtaining and using a polypeptide other than BCL-2 that affects programmed vertebrate cell death. The invention relates as well to polynucleotides encoding those polypeptides, recombinant vectors carrying those sequences,
6858391 Nod2 nucleic acids and proteins February 22, 2005
The present invention relates to intracellular signalling molecules, in particular the Nod2 protein and nucleic acids encoding the Nod2 protein. The present invention provides isolated nucleotide sequence encoding Nod2, isolated Nod2 peptides, antibodies that specifically bind Nod2, meth
6835815 Nod2 nucleic acids and proteins December 28, 2004
The present invention relates to intracellular signalling molecules, in particular the Nod2 protein and nucleic acids encoding the Nod2 protein. The present invention provides isolated nucleotide sequence encoding Nod2, isolated Nod2 peptides, antibodies that specifically bind Nod2, meth
6395510 Vertebrate apoptosis gene: compositions and methods May 28, 2002
The invention relates generally to compositions of and methods for obtaining and using a polypeptide other than BCL-2 that affects programmed vertebrate cell death. The invention relates as well to polynucleotides encoding those polypeptides, recombinant vectors carrying those sequences,
6348573 Compositions and methods for identifying apoptosis signaling pathway inhibitors and activators February 19, 2002
The invention generally relates to compositions and methods for identifying Apoptosis signaling pathway inhibitors and activators.
6303331 Vertebrate apoptosis gene: compositions and methods October 16, 2001
The invention relates generally to compositions of and methods for obtaining and using a polypeptide other than BCL-2 that affects programmed vertebrate cell death. The invention relates as well to polynucleotides encoding those polypeptides, recombinant vectors carrying those sequences,
5834309 Vertebrate apoptosis gene: compositions and methods November 10, 1998
The invention relates generally to compositions of and methods for obtaining and using a polypeptide other than BCL-2 that affects programmed vertebrate cell death. The invention relates as well to polynucleotides encoding those polypeptides, recombinant vectors carrying those sequences,
5646008 Vertebrate apoptosis gene: compositions and methods July 8, 1997
The invention relates generally to compositions of and methods for obtaining and using a polypeptide other than BCL-2 that affects programmed vertebrate cell death. The invention relates as well to polynucleotides encoding those polypeptides, recombinant vectors carrying those sequences,










 
 
  Recently Added Patents
Quantitative oxygen imaging systems and methods using echo-based single point imaging
Method and apparatus for laser strip splicing
Endotracheal tube
Driving support device, method, and program
Systems and methods for synchronizing and controlling multiple image sensors
Writing implement
Catheter with multiple electrode assemblies for use at or near tubular regions of the heart
  Randomly Featured Patents
Reciprocating lift mechanism
Method and device for supplying electronic parts
Front body structure for motor vehicle
Optical element, optical pickup unit, and optical disk drive unit
Apparatus for rotating an NMR test tube
Tread portion of an automobile tire
Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund's adjuvant
Non-volatile memory arrangement having nanocrystals
Voltage regulator, voltage regulation method, and liquid crystal display device using the same
Substituted naphthyridines and their herbicidal use